CLINICAL_TRIALS ClinicalTrials.gov record update

Rate of Alpha-synuclein in Cerebrospinal Fluid to Differentiate Patient With Alzheimer's Disease From Those With Lewy Body Disease.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01876459
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:29.427211+00:00
Published At: 2013-06-18T00:00:00+00:00
Record Updated At: 2013-06-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["\"Alzheimer\u0027s Disease\" and \"Lewy Body Disease\""]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-06-18"
protocolSection.identificationModule.nctId: "NCT01876459"
protocolSection.identificationModule.officialTitle: "Rate of Alpha-synuclein in Cerebrospinal Fluid to Differentiate Patient With Alzheimer\u0027s Disease From Those With Lewy Body Disease."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.